Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tyrosine kinase fak'

Search results for: 'research area tyrosine kinase fak'

Items 51-60 of 286

Page
per page
  1. Silvestrol
    A3818 Silvestrol
    Summary: Antineoplastic
      Soluble in DMSO
  2. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL
  3. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL
  4. (R)-Crizotinib
    A3020 (R)-Crizotinib
     2 Citation
    Target: c-MET
    Summary: C-MET/ALK inhibitor,potent and ATP-competitve
      insoluble in H2O; insoluble in EtOH; ≥7.51 mg/mL
  5. Lapatinib Ditosylate
    A3967 Lapatinib Ditosylate
    Target: EGFR|ErbB-2
    Summary: EGFR/HER2 inhibitor,potent and selective
      ≥24.3 mg/mL
  6. AC480 (BMS-599626)
    A2822 AC480 (BMS-599626)
    Target: EGFR
    Summary: HER1/2 inhibitor,selective and efficacious
      ≥28.35 mg/mL
  7. Dacomitinib (PF299804, PF299)
    A8319 Dacomitinib (PF299804, PF299)
    Target: ErbB
    Summary: HER inhibitor
      ≥23.5 mg/mL
  8. Neratinib (HKI-272)
    A8322 Neratinib (HKI-272)
     1 Citation
    Target: EGFR
    Summary: HER2/EGFR inhibitor,potent and irreversible
      insoluble in H2O; ≥13.93 mg/mL
  9. CUDC-101
    A4092 CUDC-101
     1 Citation
    Target: Histone Deacetylases (HDACs)|EGFR|ErbB
    Summary: Multitargeted HDAC inhibitor
      ≥21.7 mg/mL
  10. Nintedanib (BIBF 1120)
    A8252 Nintedanib (BIBF 1120)
     3 Citation
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL

Items 51-60 of 286

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 282item
  2. Natural Products 1 item
  3. Lab Reagents 1 item
Specificity
  1. Selective 211item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 22item
  2. Irreversible 6item
Target
  1. Cyclin-Dependent Kinases 22item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 4item
  4. PI3K 14item
  5. Raf 10item
  6. Aurora Kinases 18item
  7. CSF-1R 4item
  8. mTOR 7item
  9. FLT3 13item
  10. GSK-3 8item
  11. PLK 6item
  12. Chk 5item
  13. Eph Receptors 2item
  14. VEGFR 30item
  15. PDGFR 22item
  16. c-Kit 12item
  17. RET 4item
  18. IRAK 1 item
  19. Bromodomain-containing proteins(BRDs) 1 item
  20. p38 6item
  21. PKB 1 item
  22. JNK 1 item
  23. SGK 1 item
  24. Bcr-Abl 11item
  25. MEK 3item
  26. FGFR 12item
  27. Pim 3item
  28. Voltage-gated Sodium (NaV) Channels 1 item
  29. MET 5item
  30. Src 14item
  31. Trk Receptors 2item
  32. STAT 3item
  33. EGFR 16item
  34. ROCK 5item
  35. BTK 1 item
  36. PAK 3item
  37. FAK 7item
  38. BMP and Other Activin Receptors 2item
  39. JAK 14item
  40. Syk 5item
  41. DNA-PK 4item
  42. AMPK 2item
  43. PDHK 1 item
  44. Cytochrome P450 (CYP450) 1 item
  45. ErbB 4item
  46. S6 kinases 1 item
  47. Adenosine Kinases 2item
  48. ERK 4item
  49. c-MET 5item
  50. PKC 11item
  51. Ubiquitin-specific proteases 1 item
  52. Ca2 /calmodulin-dependent protein kinases (CaMKs) 5item
  53. Lyn 2item
  54. HER2 2item
  55. Pyk2 3item
  56. LRRK2 5item
  57. Insulin and Insulin-like Receptors 3item
  58. ALK 7item
  59. ROS1 1 item
  60. Sphingosine kinases (SphKs) 2item
  61. PKG 1 item
  62. PKA 4item
  63. Myosin light chain kinases (MLCKs) 1 item
  64. MELK 1 item
  65. Insulin-like growth factors (IGFs) 1 item
  66. MK2 2item
  67. Fatty-acid-binding proteins (FABPs) 1 item
  68. Angiotensin-Converting Enzymes (ACEs) 1 item
  69. Tie-2 2item
  70. RSK 2item
  71. phosphatases 1 item
  72. ATM/ATR 2item
  73. Farnesyl Diphosphate Synthases 1 item
  74. CK2 2item
  75. HIPK2 1 item
  76. HIPK3 1 item
  77. P2X Receptors 1 item
  78. Histamine H1 Receptors 1 item
  79. P110 1 item
  80. Hck 2item
  81. MNK 1 item
  82. 5-Lipoxygenases 1 item
  83. Insulin Receptors 1 item
  84. IRG-1R 1 item
  85. Cdc2-like kinase (Clk) 1 item
  86. eEF-2 1 item
  87. Cdc7 1 item
  88. ZAP-70 1 item
  89. c-RET 3item
  90. p70 rsk 2item
  91. VEGFR3/FLT4 1 item
  92. NTRK1/TRKA 1 item
  93. CSF-1R/c-Fms 1 item
  94. TAM kinase 1 item
  95. KDR 1 item
  96. Fyn kinase 1 item
  97. AXL 1 item
  98. c-Fms tyrosine kinase 1 item
  99. insulin 1 item
  100. MSK 1 item
  101. Lyn kinase 1 item
  102. Mer tyrosine kinase 1 item
  103. ErbB-2 1 item
  104. PDK-1 1 item
  105. Histone Acetyltransferases (HATs) 1 item
  106. Prk 1 item
  107. ITK 1 item
  108. NUAK 1 item
  109. DCLK2 1 item
  110. PTK 1 item
  111. phosphatidylinositol kinase 1 item
  112. Flk1 2item
  113. Protein Tyrosine Phosphatases 1 item
  114. alkaline phosphatases 1 item
  115. ATPases 1 item
  116. glutamate release 1 item
  117. FGR 1 item
  118. YES 2item
  119. Fyn 2item
  120. ARG 1 item
  121. TRPC channel 1 item
  122. PKD 1 item
  123. Pyruvate kinases 1 item
  124. enoyl-acyl-carrier protein reductase 1 item
  125. Rho-kinase 1 item
  126. tropomyosin receptor kinase 1 item
  127. SK 1 item
  128. PPK 1 item
  129. c-Syk 1 item
  130. CDK1/CyclinB 1 item
  131. PIM1 kinase 1 item
  132. phospholipase A2 1 item
  133. PIKfyve 1 item
  134. Insulin Receptor 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 15item
  3. Adrenocortical Carcinoma 2item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 4item
  6. Bladder Carcinoma 1 item
  7. B-lymphoid Malignancies 1 item
  8. Breast Cancer 42item
  9. Cancer 187item
  10. Cervical Cancer 4item
  11. Cholangiocarcinoma 2item
  12. Chronic Lymphocytic Leukemia 2item
  13. Clear Cell Renal Cell Carcinoma 1 item
  14. Colon Cancer 18item
  15. Colon Carcinoma 2item
  16. Colorectal Cancer 18item
  17. Glioblastoma 17item
  18. Glioma 7item
  19. Hepatocellular Carcinoma 4item
  20. HIV Infections 1 item
  21. Immunological Diseases 1 item
  22. Inflammatory Bowel Disease 1 item
  23. Inflammatory Diseases 3item
  24. Leukemia 8item
  25. Liver Cancer 3item
  26. Lung Cancer 14item
  27. Lung Carcinoma 3item
  28. Lymphoma 9item
  29. Mantle Cell Lymphoma 1 item
  30. Melanoma 11item
  31. Multiple Myeloma 4item
  32. Myelofibrosis 1 item
  33. Myeloma 1 item
  34. Neuroblastoma 2item
  35. Non-small Cell Lung Cancer 5item
  36. Non-small Cell Lung Carcinoma 1 item
  37. Ovarian Cancer 15item
  38. Pancreatic Cancer 22item
  39. Prostate Cancer 14item
  40. Psoriasis 1 item
  41. Pulmonary Arterial Hypertension 1 item
  42. Renal Cancer 3item
  43. Renal Cell Carcinoma 5item
  44. Rheumatoid Arthritis 5item
  45. Thyroid Cancer 5item
  46. Type 2 Diabetes 3item